MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2025-09-30, OVID made $132K in revenue. -$12,158K in net income. Net profit margin of -9210.61%.

Income Overview

Revenue
$132K
Net Income
-$12,158K
Net Profit Margin
-9210.61%
Unit: Thousand (K) dollars

Unit: Thousand (K) dollars (except for numbers of shares and EPS)
Income Statement
2025-09-30
2025-06-30
2025-03-31
2024-09-30
Total revenue
132 6,272 130 173
Research and development
5,870 6,465 6,659 7,855
General and administrative
6,785 4,880 6,021 5,544
Total operating expenses
12,655 11,345 12,680 13,399
Loss from operations
-12,523 -5,073 -12,550 -13,226
Other income (expense), net
365 389 2,315 -780
Loss before provision for income taxes
-12,158 -4,684 -10,235 -14,006
Provision for income taxes
0 0 --
Net loss
-12,158 -4,684 -10,235 -14,006
Basic eps
---141.57 -0.2
Diluted eps
---141.57 -0.2
Basic average shares
--1,250 70,975,778
Diluted average shares
--1,250 70,975,778
Net loss per share, basic (in dollars per share)
-168.01 ---
Net loss per share, diluted (in dollars per share)
-168.01 ---
Weighted-average common shares outstanding, basic (in shares)
1,250 ---
Weighted-average common shares outstanding, diluted (in shares)
1,250 ---
Unit: Thousand (K) dollars (except for numbers of shares and EPS)

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Net loss-$12,158K Loss beforeprovision for income taxes-$12,158K Other income(expense), net$365K Loss from operations-$12,523K Total revenue$132K Total operatingexpenses$12,655K General andadministrative$6,785K Research and development$5,870K

Ovid Therapeutics Inc. (OVID)

Ovid Therapeutics Inc. (OVID)